Descartes Systems Group, a Waterloo, Canada-based logistics technology provider, acquired Datamyne for $52.7 million, reports DCVelocity.
Supply Chain
Gilead Sciences hired cancer specialist Alessandro Riva, MD, former head of Novartis' global oncology department.
Parsippany-Troy Hills, N.J.-based Allergan earned approval from the Food and Drug Administration for its Natrelle Inspira SoftTouch breast implant, reports MassDevice.
The American Red Cross on Wednesday issued an emergency call for blood donations in response to a severe winter shortage.
As the rate of overdoses has increased, so too has the price of the antidote.
Advertisement
Reps. Erik Paulsen (R-Minn.) and Ron Kind (D-Wis.) introduced new anti-medical device tax legislation to Congress Tuesday, reports MassDevice.
A federal judge on Tuesday refused to overturn a court verdict regarding a patent dispute between Thousand Oaks, Calif.-based Amgen, Paris-based Sanofi and Tarrytown, N.Y.-based Regeneron Pharmaceuticals, reports Reuters.
As President-elect Donald Trump prepares to take office with a Republican-controlled Congress, major shifts in drug pricing policies are not expected, a new report by investment research firm Morningstar claims. However, the firm suggests ACA changes would likely focus on…
For Kelli McRory, no clinical product — from table paper to electrodes — is too small to warrant meticulous cost analysis when it comes to clinical spend management.
Amid controversial price hikes and surprising regulatory decisions, many aspects of the drug industry were scrutinized this past year.